And it's just another promise of a blockbuster device! No customer and no FDA regulatory plan much less approval or any idea how long it might take to get to market. Keith is spot on in his recent analysis!! I can't believe Ramin was given a bonus for this. Utterly outrageous!! How about no having bonuses for things unequivocally provide shareholder value...not the promise of shareholder value.
Add to My Watchlist
What is My Watchlist?